Abstract
Toll-like receptors (TLRs) have been identified as a major class of pattern-recognition receptors. Recognition of pathogen-associated molecular patterns (PAMPs) by TLRs, either alone or in heterodimerization with other TLR or non-TLR receptors, induces signals responsible for the activation of innate immune response. Recent studies have demonstrated a crucial involvement of TLRs in the recognition of fungal pathogens such as Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans. By studying fungal infection in knock-out mice deficient in either TLRs or TLRassociated adaptor molecules, it appeared that specific TLRs such as TLR2 and TLR4 play differential roles in the activation of the various arms of the innate immune response. Recent data also suggest that TLRs offer escape mechanisms to certain pathogenic microorganisms, especially through TLR2-driven induction of antiinflamatory cytokines. These recent developments provide crucial information for understanding the mechanisms of fungal recognition by cells of the immune system, and provide hope for designing new therapeutical approaches to fungal infections.
Keywords: Candida albicans, immunosuppression, pneumonia, TLR4 interaction, Cryptococcus neoformans
Current Pharmaceutical Design
Title: Recognition of Fungal Pathogens by Toll-Like Receptors
Volume: 12 Issue: 32
Author(s): Mihai G. Netea, Gerben Ferwerda, Chantal A.A. van der Graaf, Jos W. M. Van der Meer and Bart Jan Kullberg
Affiliation:
Keywords: Candida albicans, immunosuppression, pneumonia, TLR4 interaction, Cryptococcus neoformans
Abstract: Toll-like receptors (TLRs) have been identified as a major class of pattern-recognition receptors. Recognition of pathogen-associated molecular patterns (PAMPs) by TLRs, either alone or in heterodimerization with other TLR or non-TLR receptors, induces signals responsible for the activation of innate immune response. Recent studies have demonstrated a crucial involvement of TLRs in the recognition of fungal pathogens such as Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans. By studying fungal infection in knock-out mice deficient in either TLRs or TLRassociated adaptor molecules, it appeared that specific TLRs such as TLR2 and TLR4 play differential roles in the activation of the various arms of the innate immune response. Recent data also suggest that TLRs offer escape mechanisms to certain pathogenic microorganisms, especially through TLR2-driven induction of antiinflamatory cytokines. These recent developments provide crucial information for understanding the mechanisms of fungal recognition by cells of the immune system, and provide hope for designing new therapeutical approaches to fungal infections.
Export Options
About this article
Cite this article as:
Netea G. Mihai, Ferwerda Gerben, van der Graaf A.A. Chantal, Van der Meer M. Jos W. and Kullberg Bart Jan, Recognition of Fungal Pathogens by Toll-Like Receptors, Current Pharmaceutical Design 2006; 12 (32) . https://dx.doi.org/10.2174/138161206778743538
DOI https://dx.doi.org/10.2174/138161206778743538 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
NMR Screening and Hit Validation in Fragment Based Drug Discovery
Current Topics in Medicinal Chemistry Postponing Motherhood: A Demographic and Contemporary Issue
Current Women`s Health Reviews Plant Polyphenols and Tumors: From Mechanisms to Therapies, Prevention, and Protection Against Toxicity of Anti-Cancer Treatments
Current Medicinal Chemistry Clinical Use of Clopidogrel
Current Pharmaceutical Design Eigenanatomy on Fractional Anisotropy Imaging Provides White Matter Anatomical Features Discriminating Between Alzheimer’s Disease and Late Onset Bipolar Disorder
Current Alzheimer Research Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease
Current Neuropharmacology HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective
Current HIV Research Innate Immunity in the Mucosal Immune System
Current Pharmaceutical Design Heterotrimeric G Proteins Control Diverse Pathways of Transmembrane Signaling, a Base for Drug Discovery
Mini-Reviews in Medicinal Chemistry Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Anti-Cancer Agents in Medicinal Chemistry GPER and ER: Estrogen Receptors with Distinct Biological Roles in Breast Cancer
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Modulation of Interaction Between Virus and Eukaryotic Host by Exposure to S. aureus Bacterial Soluble Fractions
Current Organic Chemistry Recent Advances in Gastric Floating Drug Delivery Technology: A Review
Current Drug Delivery Monoclonal Antibodies Against Epidermal Growth Factor Receptor in Advanced Colorectal Carcinoma: Clinical Efficacy and Markers of Sensitivity&#
Reviews on Recent Clinical Trials Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19
Current Drug Delivery Ocular Complications of Drugs Used in Rheumatic Disease
Current Rheumatology Reviews Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD)
Recent Patents on Inflammation & Allergy Drug Discovery Protective Effects of Downregulating Estrogen Receptor Alpha Expression in Cervical Cancer
Anti-Cancer Agents in Medicinal Chemistry AIDS-Related Kaposis Sarcoma: State of the Art and Therapeutic Strategies
Current HIV Research Nevirapine and/or Co-Trimoxazole Induced Stevens Johnson syndrome in HIV Infected Patient - A Case Report
Current Drug Safety